# Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective

> **NCT05100277** · — · COMPLETED · sponsor: **Hospital Perola Byington** · enrollment: 155 (actual)

## Conditions studied

- Breast Cancer
- Adjuvant Treatment

## Interventions

- **GENETIC:** Oncotype DX® Assay
- **OTHER:** Cost

## Key facts

- **NCT ID:** NCT05100277
- **Lead sponsor:** Hospital Perola Byington
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-08
- **Primary completion:** 2019-02-04
- **Final completion:** 2019-02-04
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2022-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05100277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05100277, "Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05100277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*